The luteinizing hormone receptor (LHR) is a G protein-coupled receptor whose dynamic expression in ovarian granulosa and theca cells underpins key events in folliculogenesis, ovulation and luteal ...
Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor–Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker ...
Changes in cognitive function in postmenopausal women 1 year after completing adjuvant letrozole or tamoxifen in the Breast International Group (BIG) 1-98 trial. Background: To evaluate the role of ...
Melatonin Effects on Luteinizing Hormone in Postmenopausal Women: A Pilot Clinical Trial NCT00288262
Background: In many mammals, the duration of the nocturnal melatonin elevation regulates seasonal changes in reproductive hormones such as luteinizing hormone (LH). Melatonin's effects on human ...
Until recently, most women who underwent adjuvant hormone therapy to reduce the chance of a breast cancer recurrence took tamoxifen every day for 5 years. However, with the advent of newer hormone ...
Melatonin Effects on Luteinizing Hormone in Postmenopausal Women: A Pilot Clinical Trial NCT00288262
The 20 participants completing the study had a mean age of 59 years (range 51–69). As expected due to random group assignment, baseline values of urinary LH excretion among the 3 groups were not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results